
The Nixon Shock of Human Metabolism: How Pharmacological and Biometric Convergence is Rewriting Fitness Economics
The FDA's reclassification of GLP-1 agonists and the integration of continuous biomarker tracking into fitness hardware mark a paradigm shift in human...
Read Full Story →



![[The Biological Retrofit: How GLP-1 Agonists and Continuous Monitoring Are Rewiring the Fitness Economy]](https://www.crimaz.com/assets/images/no-image.png)
